![Robert Brenner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Brenner
Chief Tech/Sci/R&D Officer at
VERA THERAPEUTICS, INC.
Net worth: 291 917 $ as of 2026-06-29
Profile
Robert M.
Brenner is Chief Medical Officer at Vera Therapeutics, Inc. since 2023.
Formerly, Dr. Brenner was President & Chief Executive Officer at AlloCure, Inc. in 2010; Executive Director-Nephrology Medical Affairs at Amgen, Inc. from 1999 to 2008; Senior Vice President-Medical Affairs at AMAG Pharmaceuticals, Inc. from 2008 to 2010; Chief Medical Officer at Orionis Biosciences, Inc. from 2015 to 2018; and Executive VP-Research & Development at Codiak BioSciences, Inc. from 2018 to 2019.
Education includes undergraduate studies at The Johns Hopkins University and a doctorate from Albert Einstein College of Medicine, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-23 | 6,803 ( 0.01% ) | 291 917 $ | 2026-06-29 |
Robert Brenner active positions
| Companies | Position | Start |
|---|---|---|
| VERA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-01-07 |
Former positions of Robert Brenner
| Companies | Position | End |
|---|---|---|
| CODIAK BIOSCIENCES | Chief Tech/Sci/R&D Officer | 2019-02-28 |
Orionis Biosciences, Inc.
 Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Offers protein interaction platform with direct applications in the discovery of new therapeutics | Chief Tech/Sci/R&D Officer | 2018-08-31 |
| AMAG PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2010-06-03 |
| AMGEN INC. | Corporate Officer/Principal | 2008-04-30 |
AlloCure, Inc.
 AlloCure, Inc. BiotechnologyHealth Technology Develops cell therapies for the treatment of kidney diseases, organ transplants and multi-organ injuries | Chief Executive Officer | 2010-12-27 |
Training of Robert Brenner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
85
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
AlloCure, Inc.
AlloCure, Inc. BiotechnologyHealth Technology Develops cell therapies for the treatment of kidney diseases, organ transplants and multi-organ injuries | Health Technology |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Orionis Biosciences, Inc.
Orionis Biosciences, Inc. Packaged SoftwareTechnology Services Offers protein interaction platform with direct applications in the discovery of new therapeutics | Technology Services |
Codiak BioSciences, Inc.
 Codiak BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops exosome based therapeutics | Health Technology |
Vera Therapeutics, Inc.
 Vera Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company, which focuses on development and treatments for immunological & inflammatory diseases | Health Technology |
- Stock Market
- Insiders
- Robert Brenner
